Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.
MIT researchers created an mRNA-based vaccine adjuvant that significantly enhances T-cell activity, improving cancer tumor elimination and potentially strengthening infectious disease vaccines
The FDA launched a new program to systematically review food chemicals and has started reassessing the safety of additives BHT and ADA with public…
NIH-supported study shows combining cardiac MRI, blood biomarkers, and clinical data improves prediction of adverse events in hypertrophic cardiomyopathy patients
The CDC’s acting director said the hantavirus outbreak linked to a cruise ship is serious but does not pose the same public health threat…
The FDA invites public feedback to identify new uses for approved drugs, aiming to accelerate treatments for diseases lacking effective options
WHO Director-General Tedros Adhanom Ghebreyesus arrived in Tenerife to oversee evacuations of a cruise ship affected by a rare hantavirus outbreak
The FDA authorized Bizengri to treat adults with advanced cholangiocarcinoma with NRG1 gene fusion, marking the seventh approval under its National Priority Voucher pilot…
The FDA released final guidance outlining methods to improve postapproval studies on drug safety during pregnancy, aiming to provide clearer information for healthcare providers…
A rare hantavirus strain linked to a Dutch cruise ship has infected at least eight people, with three deaths reported and global health authorities…
The FDA has introduced one-day inspectional assessments to improve targeted oversight and expand facility coverage while maintaining regulatory standards
